definiens: means ( i ) [COMPANY] Compounds, ( ii ) [COMPANY] Compounds . ( iii ) compOlmds which at the time of filing and/or at the time of grant are Covered by a compound claim of an [COMPANY] Patent Rigllt and/or a [COMPANY] Licensed Patent Right . ( iv ) Retained Compounds, ( v ) Released Compounds, and ( vi ) compounds that ( a ) are conceived or reduced to practice during the Combined Period o€ve ( s}ears thereafter, ( b ) are Amine Neurotransmitter Reuptake Inhibitors, and ( c ) are based on and/or derived fi'om a compound of any of items ( i ) -(v ) above . For the 17 CONFIDENTIAL avoidance of doubt, a compound claim of item ( iii ) excludes any fonnulation, process, method of use, or combination claim and is limited to a claim that claims a compound per se